What does CUSIP 45780V102 represent in this 13F holders report?

CUSIP 45780V102 is the security identifier for ITEK - INOTEK PHARMACEUTICALS CORP - COM used to aggregate holder disclosures.

How many institutions held ITEK - INOTEK PHARMACEUTICALS CORP - COM in Q3 2016?

78 institutional investors reported ITEK - INOTEK PHARMACEUTICALS CORP - COM for Q3 2016. Use the holders table for investor-level position and value details.

INOTEK PHARMACEUTICALS CORP - COM (ITEK)

CUSIP: 45780V102

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class: Equity / COM
Total 13F shares: 21,794,703
Share change: +2,042,743
Total reported value: $206,607,778
Put/Call ratio: 1060%
Price per share: $9.48
Number of holders: 78
Value change: +$19,450,707
Number of buys: 44
Number of sells: 20

Quarterly Holders Quick Answers

What is CUSIP 45780V102?
CUSIP 45780V102 identifies ITEK - INOTEK PHARMACEUTICALS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2016
Previous quarter: Q2 2016

Recent filing periods for CUSIP 45780V102:

Q4 2021 Q3 2021 Q1 2018 Q4 2017 Q3 2017 Q2 2017 Q1 2017 Q4 2016

Institutional Holders of INOTEK PHARMACEUTICALS CORP - COM (ITEK) as of Q3 2016

As of 30 Sep 2016, INOTEK PHARMACEUTICALS CORP - COM (ITEK) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,794,703 shares. The largest 10 holders included Devon Park Associates, LLC, RHO CAPITAL PARTNERS INC, JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, Point72 Asset Management, L.P., BlackRock Fund Advisors, BlackRock Advisors LLC, and VANGUARD GROUP INC. This page lists 78 institutional shareholders reporting positions in this security for the Q3 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.